Clinical Trial

A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fasting Conditions

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 3, 2026 (before its estimated August 3, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this clinical trial is to compare the blood tafamidis concentration of healthy adult participants after taking two different forms of tafamidis by under fasted conditions.
Protocol Amendment History 3 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-04
notable Enrollment reduced: 30 -> 15 participants 2026-06-04
critical Recruitment opened 2026-05-23
Trial Details
NCT Number NCT07587697
Lead Sponsor Pfizer
Conditions Healthy Adults
Enrollment 15 participants
Start Date 2026-05-11
Primary Completion 2026-08-03 (estimated)
Study Completion 2026-08-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-03